These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders. Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006 [TBL] [Abstract][Full Text] [Related]
6. [Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms]. Torregrosa JM; Soler G; Cancio S; Ferrer-Marin F Med Clin (Barc); 2015 Oct; 145(7):318-9. PubMed ID: 25618739 [No Abstract] [Full Text] [Related]
7. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms. Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163 [TBL] [Abstract][Full Text] [Related]
8. An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion? Langabeer SE Eur J Intern Med; 2018 Jun; 52():e37-e38. PubMed ID: 29622375 [No Abstract] [Full Text] [Related]
10. Neutrophilia and the JAK2 V617F Mutation. Langabeer SE; Haslam K Pathol Oncol Res; 2019 Jan; 25(1):437-438. PubMed ID: 28944411 [No Abstract] [Full Text] [Related]
11. JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases. Godeneche G; Gaillard N; Roy L; Mania A; Tondeur S; Chomel JC; Lavabre T; Arquizan C; Neau JP Cerebrovasc Dis; 2010 Jan; 29(2):206-9. PubMed ID: 20029191 [No Abstract] [Full Text] [Related]
12. Splenomegaly and the JAK2 V617F mutation. Langabeer SE Eur J Intern Med; 2017 Jan; 37():e45-e46. PubMed ID: 27727073 [No Abstract] [Full Text] [Related]
13. JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Rumi E; Passamonti F; Pietra D; Della Porta MG; Arcaini L; Boggi S; Elena C; Boveri E; Pascutto C; Lazzarino M; Cazzola M Cancer; 2006 Nov; 107(9):2206-11. PubMed ID: 16998940 [TBL] [Abstract][Full Text] [Related]
14. Plummer-Vinson syndrome and reactive thrombocytosis mask a JAK2-V617F positive myeloproliferative neoplasm. Scott EC; Schuster S Blood; 2011 Dec; 118(23):5988. PubMed ID: 22238785 [No Abstract] [Full Text] [Related]
15. What is the role of JAK2(V617F) mutation in leukemic transformation of myeloproliferative neoplasms? Lopes da Silva R; Ribeiro P; Lourenço A; Santos SC; Santos M; Costa I; de Sousa AB Lab Hematol; 2011 Mar; 17(1):12-6. PubMed ID: 21421540 [TBL] [Abstract][Full Text] [Related]
16. JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects. Benmoussa A; Dehbi H; Fehri S; Quessar A; Nadifi S Pathol Biol (Paris); 2011 Aug; 59(4):e89-92. PubMed ID: 19939582 [TBL] [Abstract][Full Text] [Related]
17. JAK2 V617F Mutation Testing in Patients Presenting With Hepatic and Portal Vein Thrombosis. Foucar CE; Stein BL JAMA; 2017 Jun; 317(21):2228-2229. PubMed ID: 28586872 [No Abstract] [Full Text] [Related]
18. Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders. Basquiera AL; Soria NW; Ryser R; Salguero M; Moiraghi B; Sackmann F; Sturich AG; Borello A; Berretta A; Bonafé M; Barral JM; Palazzo ED; García JJ Hematology; 2009 Dec; 14(6):323-30. PubMed ID: 19941738 [TBL] [Abstract][Full Text] [Related]
19. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211 [TBL] [Abstract][Full Text] [Related]
20. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis. Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]